Qube Research & Technologies LTD Abb Vie Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 740,538 shares of ABBV stock, worth $144 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

740,538

Previous 1,283,961 42.32%

Holding current value

$144 Million

Previous $234 Million 45.67%

% of portfolio

0.2%

Previous 0.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $84.1 Million - $98.2 Million	-543,423 Reduced 42.32%	740,538 $127 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $14.3 Million - $16.2 Million	89,165 Added 7.46%	1,283,961 $234 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $116 Million - $130 Million	841,342 Added 238.03%	1,194,796 $185 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $74.3 Million - $86 Million	-555,882 Reduced 61.13%	353,454 $52.7 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $120 Million - $150 Million	909,336 New	909,336 $123 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $15.8 Million - $19 Million	114,346 Added 2524.19%	118,876 $19.2 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $3.05 Million - $3.5 Million	-22,708 Reduced 83.37%	4,530 $608,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $2.79 Million - $3.54 Million	20,238 Added 289.11%	27,238 $4.17 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $923,859 - $1.15 Million	7,000 New	7,000 $1.14 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $222,594 - $281,646	-2,072 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $24.1 Million - $27.4 Million	-226,548 Reduced 99.09%	2,072 $224,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $20.9 Million - $23.3 Million	198,619 Added 662.04%	228,620 $25.8 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $3.07 Million - $3.38 Million	30,001 New	30,001 $3.25 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $23.3 Million - $31.5 Million	-289,815 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $8.43 Million - $9.89 Million	98,130 Added 51.19%	289,815 $25.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $14.1 Million - $18.8 Million	191,685 New	191,685 $18.8 Million
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $3.47 Million - $4.44 Million	-52,823 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $2.73 Million - $3.21 Million	35,375 Added 202.75%	52,823 $4.26 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $776,865 - $958,083	-9,979 Reduced 36.38%	17,448 $1.61 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.21 Million - $1.35 Million	13,609 Added 98.49%	27,427 $2.59 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $974,741 - $1.15 Million	10,857 Added 366.67%	13,818 $1.28 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $272,441 - $364,824	2,961 New	2,961 $280,000

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Abb Vie Inc. Transaction History